Boston Partners’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-90,431
| Closed | -$1.29M | – | 700 |
|
|
2019
Q1 | $1.29M | Sell |
90,431
-18,674
| -17% | -$266K | ﹤0.01% | 606 |
|
|
2018
Q4 | $1.25M | Sell |
109,105
-25,519
| -19% | -$292K | ﹤0.01% | 619 |
|
|
2018
Q3 | $2.69M | Sell |
134,624
-32,528
| -19% | -$650K | ﹤0.01% | 567 |
|
|
2018
Q2 | $4.18M | Sell |
167,152
-3,074
| -2% | -$76.9K | 0.01% | 493 |
|
|
2018
Q1 | $4.38M | Sell |
170,226
-44,618
| -21% | -$1.15M | 0.01% | 503 |
|
|
2017
Q4 | $5.49M | Sell |
214,844
-34,131
| -14% | -$872K | 0.01% | 477 |
|
|
2017
Q3 | $6.98M | Buy |
248,975
+16,196
| +7% | +$454K | 0.01% | 449 |
|
|
2017
Q2 | $6.98M | Sell |
232,779
-28,881
| -11% | -$866K | 0.01% | 428 |
|
|
2017
Q1 | $7.8M | Sell |
261,660
-38,690
| -13% | -$1.15M | 0.01% | 426 |
|
|
2016
Q4 | $10.4M | Sell |
300,350
-12,022
| -4% | -$416K | 0.01% | 401 |
|
|
2016
Q3 | $20.6M | Sell |
312,372
-16,980
| -5% | -$1.12M | 0.03% | 317 |
|
|
2016
Q2 | $18.7M | Sell |
329,352
-1,952
| -0.6% | -$111K | 0.03% | 311 |
|
|
2016
Q1 | $19.3M | Buy |
331,304
+13,312
| +4% | +$776K | 0.03% | 299 |
|
|
2015
Q4 | $18.7M | Buy |
317,992
+8,518
| +3% | +$501K | 0.03% | 306 |
|
|
2015
Q3 | $17.7M | Buy |
309,474
+83,780
| +37% | +$4.79M | 0.03% | 308 |
|
|
2015
Q2 | $20.4M | Buy |
225,694
+59,626
| +36% | +$5.38M | 0.03% | 302 |
|
|
2015
Q1 | $16M | Buy |
166,068
+113,348
| +215% | +$10.9M | 0.02% | 338 |
|
|
2014
Q4 | $4.62M | Buy |
+52,720
| New | +$4.62M | 0.01% | 539 |
|
|
2013
Q4 | – | Sell |
-6,825
| Closed | -$743K | – | 727 |
|
|
2013
Q3 | $743K | Sell |
6,825
-22,230
| -77% | -$2.42M | ﹤0.01% | 647 |
|
|
2013
Q2 | $2.45M | Buy |
+29,055
| New | +$2.45M | 0.01% | 574 |
|